Skip to main content
. 2022 Oct 17;30(2):267–276. doi: 10.1038/s41417-022-00541-7

Fig. 2. cSNX1.3 driven tumor regression in WAP-TGFα transgenic mice.

Fig. 2

Mice were bred continuously to induce transgene expression and palpated weekly for tumor formation. Once tumors reached 100 mm3, mice were entered into the study and given 10 µg/g body weight intravenous injections of either cPTD4 or cSNX1.3 3X/week. A Changes in tumor size from entry into study until end of study are shown for each individual tumor, (*) indicate tumors that entered the study at size greater than 500 mm3, all other tumors entered the study at ~100 mm3. B a Kaplan-Meier survival curve was generated showing when mice were sacrificed by either reaching tumor burden (2000 mm3) or the end of the study (p = 0.0002). C Upon sacrifice tumors were harvested and fixed in 10% formalin and embedded in paraffin. FFPE blocks were sectioned at 4 μM and stained with hematoxylin and eosin and imaged at 20x. D Protein lysates were generated from tumors upon the sacrifice and probed for the indicated proteins.